Aromatase Inhibitors: clinical trials recruiting now
Fewer than 3 recruiting trials found.
2
Recruiting trials
2
Conditions studied
0
US states with sites
1
Countries
Phase breakdown
Phase 2 2
Conditions being studied
| Condition | Trials |
|---|---|
| Breast cancer | 2 |
| HR+/HER2+ Early Breast Cancer | 2 |
Recruiting trials involving Aromatase Inhibitors
- Efficacy and Safety of Culmerciclib Plus Aromatase Inhibitors in a Response-Adapted Neoadjuvant Strategy for Highly Proliferative ER-Positive/HER2-Negative Breast Cancer
- Fovinaciclib Plus Aromatase Inhibitors and Dual HER2 Blockade in a Response-Adapted Neoadjuvant Strategy for HR-Positive/HER2-Positive Early Breast Cancer
Common questions
How many recruiting trials involve Aromatase Inhibitors?
2 recruiting trials across 2 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.